Nasic (Xylometazoline Hydrochloride, Dexpanthenol)

Xylometazoline Hydrochloride selectively stimulates alpha‑adrenergic receptors on the blood vessels of the nasal mucosa. This causes vasoconstriction, which reduces swelling and excess fluid, opening the nasal passages and decreasing the sensation of congestion.

The exact dose of Nasic is determined by the prescribing healthcare professional. Typically, a few sprays into each nostril are administered, but the prescriber will specify the number of sprays, frequency and duration based on the individual’s condition.

Safety data for Xylometazoline Hydrochloride and Dexpanthenol in pregnancy or lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using Nasic to weigh potential benefits against risks.

To order Nasic, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nasic combines a fast‑acting alpha‑adrenergic decongestant (Xylometazoline) with Dexpanthenol, which promotes mucosal healing. Compared with single‑ingredient sprays such as oxymetazoline, Nasic may offer added moisturising benefits, though the core decongestant effect is similar.

Store Nasic at room temperature, preferably below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children.

Nasic is administered as a nasal spray. The user should gently blow the nose, tilt the head slightly forward, insert the nozzle into one nostril, and press the pump to deliver the recommended number of sprays. The process is repeated in the other nostril if advised.

Serious but rare risks include persistent nasal irritation or ulceration, severe hypertension, allergic reactions such as rash or swelling, and, in extremely uncommon cases, perforation of the nasal septum. Any of these symptoms should prompt immediate medical attention.

Nasic should be avoided in individuals with known hypersensitivity to Xylometazoline, Dexpanthenol or any excipients, in children under two years of age unless directed by a physician, and in patients with severe hypertension or recent nasal surgery without professional guidance.